BR112014010719A2 - moduladores não competitivos de receptor nicotínico - Google Patents

moduladores não competitivos de receptor nicotínico

Info

Publication number
BR112014010719A2
BR112014010719A2 BR112014010719A BR112014010719A BR112014010719A2 BR 112014010719 A2 BR112014010719 A2 BR 112014010719A2 BR 112014010719 A BR112014010719 A BR 112014010719A BR 112014010719 A BR112014010719 A BR 112014010719A BR 112014010719 A2 BR112014010719 A2 BR 112014010719A2
Authority
BR
Brazil
Prior art keywords
nicotinic receptor
receptor modulators
competitive
compounds
competitive nicotinic
Prior art date
Application number
BR112014010719A
Other languages
English (en)
Inventor
Singh Bhatti Bahwinder
Yohannes Daniel
Speake Jason
Genus John
Rao Akireddy Srinivasa
Xiao Yunde
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of BR112014010719A2 publication Critical patent/BR112014010719A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

resumo patente de invenção: "moduladores não competitivos de receptor nicotínico". a presente invenção se refere a compostos que modulam receptores nicotínicos como antagonistas não competitivos. a presente invenção refere-se ainda a métodos para a síntese dos mesmos. são ainda descritas composições farmacêuticas compreendendo os referidos compostos, bem como usos e métodos empregados no tratamento ou na prevenção de uma doença ou condição mediada por um receptor nicotínico neuronal.
BR112014010719A 2011-11-03 2012-11-01 moduladores não competitivos de receptor nicotínico BR112014010719A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161554998P 2011-11-03 2011-11-03
PCT/US2012/062940 WO2013067105A2 (en) 2011-11-03 2012-11-01 Nicotinic receptor non-competitive modulators

Publications (1)

Publication Number Publication Date
BR112014010719A2 true BR112014010719A2 (pt) 2017-05-02

Family

ID=48193026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014010719A BR112014010719A2 (pt) 2011-11-03 2012-11-01 moduladores não competitivos de receptor nicotínico

Country Status (14)

Country Link
US (1) US20140288185A1 (pt)
EP (1) EP2773609A4 (pt)
JP (1) JP2014532708A (pt)
KR (1) KR20140098115A (pt)
AU (1) AU2012332545A1 (pt)
BR (1) BR112014010719A2 (pt)
CA (1) CA2853282A1 (pt)
CL (1) CL2014001137A1 (pt)
IL (1) IL232240A0 (pt)
MX (1) MX2014005216A (pt)
RU (1) RU2014122338A (pt)
SG (1) SG11201401984VA (pt)
WO (1) WO2013067105A2 (pt)
ZA (1) ZA201403502B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290215A (en) * 1963-10-29 1966-12-06 Du Pont Use of methanoindanamines as antiviral agents
US3317387A (en) * 1964-05-25 1967-05-02 Du Pont Method of reducing the severity of influenza virus infections
TW200306189A (en) * 2002-03-21 2003-11-16 Merz Pharma Gmbh & Co Kgaa Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
RU2582339C2 (ru) * 2010-05-27 2016-04-27 Таргасепт, Инк. Неконкурентные антагонисты никотиновых рецепторов

Also Published As

Publication number Publication date
EP2773609A4 (en) 2015-06-24
ZA201403502B (en) 2015-12-23
CL2014001137A1 (es) 2014-08-18
JP2014532708A (ja) 2014-12-08
CA2853282A1 (en) 2013-05-10
WO2013067105A2 (en) 2013-05-10
AU2012332545A1 (en) 2014-05-29
KR20140098115A (ko) 2014-08-07
US20140288185A1 (en) 2014-09-25
EP2773609A2 (en) 2014-09-10
MX2014005216A (es) 2014-08-22
RU2014122338A (ru) 2015-12-10
WO2013067105A3 (en) 2013-07-11
SG11201401984VA (en) 2014-05-29
IL232240A0 (en) 2014-06-30

Similar Documents

Publication Publication Date Title
BR112015015468B8 (pt) Composto, e, composição farmacêutica
BR112015031903A2 (pt) composto, sal farmaceuticamente aceitável do composto, composição farmacêutica e utilização de um composto
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112015012555A2 (pt) derivados de benzimidazol como antagonistas de ep4
BR112015022566A2 (pt) composto e composição farmacêutica
BR112014029868A2 (pt) compostos, e, composição farmacêutica
BR112015020389A8 (pt) compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos
DOP2014000115A (es) Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1
CL2013001340A1 (es) Compuestos derivados de isoindol-amida, pirrolo-piridin-amida y pirrolo-pirimimidin-amida, inhibidores de nampt y rock; composicion farmaceutica; y metodo para tratar hiperetension, insuficiencia cardiaca cronica, aterosclerosis, asma, enfermedad de alzheimer, enfermedad de parkinson y glaucoma, entre otras enfermedades.
BR112015014372A2 (pt) inibidores de autotaxina
BR112015030595A2 (pt) moduladores de receptor de estrogênio de azetidina e usos dos mesmos
BR112012027034A2 (pt) inibidores da arginase e suas aplicações terapêuticas
BR112014016165A2 (pt) compostos de benzaldeído substituído e métodos para seu uso no aumento da oxigenação do tecido
CL2012003211A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso para preparar los compuestos; composicion farmaceutica que comprende a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento o prevencion de diabetes tipo 2, obesidad y condiciones relacionadas
BR112014026952A2 (pt) derivados de aminopirimidina pirazol como moduladores lrrk2
BR112013006344A2 (pt) lactamas substituídas por piperdinila como moduladores de gpr119, composição farmacêutica as compreendendo, uso e processso para preparação das mesmas
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
EA201490888A1 (ru) Новые производные пурина и их применение для лечения заболевания
CU20140037A7 (es) Derivados de estra- 1,3,5(10), 16- tetraen- 3- carboximida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
BR112015010136A2 (pt) derivados de oxazolidin-2-ona-pirimidina
DOP2015000005A (es) Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
BR112013030391A2 (pt) derivados de piperidina 3- espirocíclicos como agonistas dos receptores de grelina
PH12014501891A1 (en) Substituted chroman compounds as calcium sensing receptor modulators

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]